138 related articles for article (PubMed ID: 25665244)
1. Cervical cancer screening: new advances bring new controversies.
Wan WH
MLO Med Lab Obs; 2014 Oct; 46(10):26, 28. PubMed ID: 25665244
[No Abstract] [Full Text] [Related]
2. A model for the implementation of cervical cancer screening and human papillomavirus vaccination in the ED: a pilot study.
Devine AS; Mason J; Rankins N; Favor TT; Baur V; Parker R; Baddorf S; McCarthy M; Ford L; Cunningham TD
Am J Emerg Med; 2016 Mar; 34(3):648. PubMed ID: 26851060
[No Abstract] [Full Text] [Related]
3. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
4. Controversies in cervical cancer screening.
Schorge JO
Clin Obstet Gynecol; 2013 Mar; 56(1):1-2. PubMed ID: 23318572
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of cervical cancer prevention.
Esselen KM; Feldman S
Clin Obstet Gynecol; 2013 Mar; 56(1):55-64. PubMed ID: 23318570
[TBL] [Abstract][Full Text] [Related]
6. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting.
Schiffman M; Solomon D
N Engl J Med; 2013 Dec; 369(24):2324-31. PubMed ID: 24328466
[No Abstract] [Full Text] [Related]
7. [Papsmears: An endless story of an announced death?].
Cochand-Priollet B
Ann Pathol; 2019 Dec; 39(6):375-377. PubMed ID: 31839115
[No Abstract] [Full Text] [Related]
8. Summaries for Patients. Cervical Cancer Screening in Average-Risk Women.
Ann Intern Med; 2015 Jun; 162(12):I-28. PubMed ID: 25928137
[No Abstract] [Full Text] [Related]
9. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
10. Cutting cervical cancer: organizations and researchers strive to improve screening, prevention.
Printz C
Cancer; 2014 Aug; 120(16):2381-2. PubMed ID: 25099731
[No Abstract] [Full Text] [Related]
11. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme.
Oteng B; Marra F; Lynd LD; Ogilvie G; Patrick D; Marra CA
Sex Transm Infect; 2011 Feb; 87(1):52-7. PubMed ID: 20956352
[TBL] [Abstract][Full Text] [Related]
12. Current status and future trends in cervical cancer screening.
Castle P; Dowdall M
Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
[No Abstract] [Full Text] [Related]
13. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both?
Perkins RB; Stier EA
Ann Intern Med; 2014 Aug; 161(4):295-7. PubMed ID: 24912666
[No Abstract] [Full Text] [Related]
14. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
Almonte M; Sasieni P; Cuzick J
Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
[TBL] [Abstract][Full Text] [Related]
15. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
16. Attitudes toward self-sampling for cervical cancer screening among primary care attendees living on the US-Mexico border.
Penaranda E; Molokwu J; Hernandez I; Salaiz R; Nguyen N; Byrd T; Shokar N
South Med J; 2014 Jul; 107(7):426-32. PubMed ID: 25010584
[TBL] [Abstract][Full Text] [Related]
17. The role of general practitioners in the continued success of the National Cervical Screening Program.
Munro A; Pavicic H; Leung Y; Westoby V; Steel N; Semmens J; O'Leary P
Aust Fam Physician; 2014 May; 43(5):293-6. PubMed ID: 24791771
[TBL] [Abstract][Full Text] [Related]
18. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
19. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer: what is the optimal age for routine testing?
Rob L; Tachezy R; Robova H
Future Oncol; 2015; 11(8):1137-40. PubMed ID: 25832869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
